513
Views
11
CrossRef citations to date
0
Altmetric
Review

Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence

, , &
Pages 139-147 | Received 20 Jul 2017, Accepted 31 Oct 2017, Published online: 08 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Georgi Tchernev, Ani Bitolska & James W Patterson. (2021) Telmisartan (and/or nitrosamine) - induced occult melanoma: first reported case in world literature. Expert Review of Clinical Pharmacology 14:9, pages 1075-1080.
Read now
Gajin Park, Wen Qian, Mei-Jie Zhang, Yi-He Chen, Li-Wen Ma, Ni Zeng, Qian Lu, Yue-Yue Li, Wei-Wei Ma, Xu-Feng Yin, Bing-Rong Zhou & Dan Luo. (2021) Platelet-rich plasma regulating the repair of ultraviolet B–induced acute tissue inflammation: adjusting macrophage polarization through the activin receptor–follistatin system. Bioengineered 12:1, pages 3125-3136.
Read now

Articles from other publishers (9)

Ruby Tow, Samuel Hanoun, Bradley Andresen, Ayaz Shahid, Jeffrey Wang, Kristen M. Kelly, Frank L. MeyskensJr.Jr. & Ying Huang. (2023) Recent Advances in Clinical Research for Skin Cancer Chemoprevention. Cancers 15:15, pages 3819.
Crossref
Jin Zhang, Quyang Yang, Jinyan Wu, Ruoyue Yuan, Xiansheng Zhao, Yue Li, Xiujun Cheng, Baojin Wu & Ningwen Zhu. (2023) Trends in cutaneous squamous cell carcinoma on the lip incidence and mortality in the United States, 2000–2019. Frontiers in Oncology 13.
Crossref
Margarita Neganova, Junqi Liu, Yulia Aleksandrova, Sergey Klochkov & Ruitai Fan. (2021) Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment. Cancers 13:23, pages 6062.
Crossref
Neil K. Mehta, Shaun A. Nguyen, Brent A. Chang & Cherie-Ann Nathan. (2021) Trend Analysis of Cutaneous Squamous Cell Carcinoma of the External Lip From 1975 to 2016. JAMA Otolaryngology–Head & Neck Surgery 147:7, pages 624.
Crossref
Jonas A. Adalsteinsson, Sonal Muzumdar, Reid Waldman, Chaoran Hu, Rong Wu, Désirée Ratner, Jonathan Ungar, Jonathan I. Silverberg, Gudridur H. Olafsdottir, Arni Kjalar Kristjansson, Laufey Tryggvadottir & Jon Gunnlaugur Jonasson. (2021) Anti–tumor necrosis factor therapy is associated with increased in situ squamous cell carcinoma of the skin: A population-based case-control study. Journal of the American Academy of Dermatology 84:6, pages 1760-1762.
Crossref
Xin-Qi Li, Ai-Ping Li, Ke Li, Xue-Mei Qin & Yue-Tao Liu. (2020) Metabonomics approach reveals the vital role of Huangqi in Huangqi Jianzhong tang against chronic atrophic gastritis coupled with molecular docking and BAWP. Chemometrics and Intelligent Laboratory Systems 200, pages 103984.
Crossref
Ettore Silvagni, Alessandra Bortoluzzi, Giovanni Ciancio & Marcello Govoni. (2019) Biological and synthetic target DMARDs in psoriatic arthritis. Pharmacological Research 149, pages 104473.
Crossref
Georgi Tchernev & Ivanka Temelkova. (2019) Irbesartan Induced Cutaneous Melanoma! Second Case in the Medical Literature!. Open Access Macedonian Journal of Medical Sciences 7:1, pages 121-123.
Crossref
Georgi Tchernev & Ivanka Temelkova. (2019) Drug-Induced Melanoma: Irbesartan Induced Cutaneous Melanoma! First Description in the World Literature!. Open Access Macedonian Journal of Medical Sciences 7:1, pages 114-116.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.